Development of gene silencing pyrrole-imidazole polyamide targeting the TGF-beta1 promoter for treatment of progressive renal diseases.

Pyrrole-imidazole (Py-Im) polyamides are nuclease-resistant novel compounds that inhibit gene expression by binding to the minor groove of DNA. A Py-Im polyamide that targets rat TGF-beta1 was designed as a gene-silencing agent for progressive renal diseases, and the distribution and the effects of this polyamide on renal injury were examined in Dahl-salt sensitive (Dahl-S) rats. For identification of transcription factor binding elements for activation of the rat TGF-beta1 gene, recombinant TGF-beta1 reporter plasmids were transfected into HEK-293 cells, and promoter activity was measured. Py-Im polyamide was designed to the activator protein-1 binding site of the rat TGF-beta1 promoter. This Py-Im polyamide showed strong, fast, and specific binding to the target DNA in gel mobility shift and Biacore assays. Py-Im polyamide significantly inhibited TGF-beta1 promoter activity and expression of TGF-beta1 mRNA and protein in rat mesangial cells. Intravenously administered fluorescein-labeled polyamide distributed to the kidney of rats. Py-Im polyamide significantly inhibited expression of TGF-beta1 mRNA and protein in the renal cortex of Dahl-S rats and reduced the increase in urinary protein and albumin in Dahl-S rats independent of changes in blood pressure. These results indicate that Py-Im polyamide that targets TGF-beta1 will be a novel gene-silencing agent for the TGF-beta1-associated diseases, including progressive renal diseases.

[1]  M. Sporn,et al.  Some recent advances in the chemistry and biology of transforming growth factor-beta , 1987, The Journal of cell biology.

[2]  W. Mckeehan,et al.  Transforming growth factor type beta specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[3]  K. Alitalo,et al.  Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation , 1989, Molecular and cellular biology.

[4]  M. Sporn,et al.  Activation of the second promoter of the transforming growth factor-beta 1 gene by transforming growth factor-beta 1 and phorbol ester occurs through the same target sequences. , 1989, The Journal of biological chemistry.

[5]  K. Matsumoto,et al.  Production of interleukin 1 in glomerular cell cultures from rats with nephrotoxic serum nephritis. , 1989, Clinical and experimental immunology.

[6]  M. Sporn,et al.  Characterization of the mouse transforming growth factor-beta 1 promoter and activation by the Ha-ras oncogene , 1991, Molecular and cellular biology.

[7]  E Ruoslahti,et al.  Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Y. Akai,et al.  Intraglomerular expression of transforming growth factor‐beta 1 (TGF‐β1) mRNA in patients with glomerulonephritis: quantitative analysis by competitive polymerase chain reaction , 1994, Clinical and experimental immunology.

[9]  C. Nast,et al.  Expression of transforming growth factor-beta isoforms in human glomerular diseases. , 1996, Kidney international.

[10]  J. Trauger,et al.  Recognition of DNA by designed ligands at subnanomolar concentrations , 1996, Nature.

[11]  M. Fujishima,et al.  Transforming growth factor-beta 1 in hypertensive renal injury in Dahl salt-sensitive rats. , 1996, Journal of the American Society of Nephrology : JASN.

[12]  C. Nast,et al.  Expression of transforming growth factor-β isoforms in human glomerular diseases , 1996 .

[13]  P. Dervan,et al.  On the pairing rules for recognition in the minor groove of DNA by pyrrole-imidazole polyamides. , 1997, Chemistry & biology.

[14]  L. Wakefield,et al.  Recharacterization of the start sites for the major human transforming growth factor-beta 1 mRNA. , 1997, Gene.

[15]  G. Jerums,et al.  Renal expression of transforming growth factor-beta inducible gene-h3 (beta ig-h3) in normal and diabetic rats. , 1998, Kidney international.

[16]  P. Sanders,et al.  Dietary salt modulates renal production of transforming growth factor-β in rats. , 1998, American journal of physiology. Renal physiology.

[17]  J. Trauger,et al.  Inhibition of RNA polymerase II transcription in human cells by synthetic DNA-binding ligands. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[18]  L. Wakefield,et al.  Identification of the start sites for the 1.9- and 1.4-kb rat transforming growth factor-beta1 transcripts and their effect on translational efficiency. , 1998, Gene.

[19]  P. Sanders,et al.  Dietary salt modulates renal production of transforming growth factor-beta in rats. , 1998, The American journal of physiology.

[20]  T. Heinemeyer,et al.  Databases on transcriptional regulation : TRANSFAC , TRRD and COMPEL , 1997 .

[21]  David W. Johnson,et al.  Renal expression of transforming growth factor-β inducible gene-h3 (βig-h3) in normal and diabetic rats1 , 1998 .

[22]  G. Wolf,et al.  Molecular mechanisms of diabetic renal hypertrophy. , 1999, Kidney international.

[23]  H. Brady,et al.  Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis. , 2000, Kidney international.

[24]  P. Dervan,et al.  Molecular recognition of DNA by small molecules. , 2001, Bioorganic & medicinal chemistry.

[25]  H. Kawachi,et al.  Effects of anti-TGF-beta type II receptor antibody on experimental glomerulonephritis. , 2001, Kidney international.

[26]  H. Yokoi,et al.  Role of connective tissue growth factor in profibrotic action of transforming growth factor-beta: a potential target for preventing renal fibrosis. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  L. Pennacchio,et al.  Genomic strategies to identify mammalian regulatory sequences , 2001, Nature Reviews Genetics.

[28]  Noboru Fukuda,et al.  Transforming growth factor-beta expression in cardiovascular organs in stroke-prone spontaneously hypertensive rats with the development of hypertension. , 2002, Hypertension research : official journal of the Japanese Society of Hypertension.

[29]  E. Greene,et al.  TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells. , 2002, American journal of physiology. Renal physiology.

[30]  H. Sugiyama,et al.  Sequence-specific protection of plasmid DNA from restriction endonuclease hydrolysis by pyrrole-imidazole-cyclopropapyrroloindole conjugates. , 2002, Nucleic acids research.

[31]  P. Dervan,et al.  Cellular uptake of N-methylpyrrole/N-methylimidazole polyamide-dye conjugates. , 2002, Bioorganic & medicinal chemistry.

[32]  H. Sugiyama,et al.  Molecular design of a pyrrole-imidazole hairpin polyamides for effective DNA alkylation. , 2002, Chemistry.

[33]  S. Ledbetter,et al.  Antihypertensive effects of chronic anti-TGF-β antibody therapy in Dahl S rats , 2002 .

[34]  R. Kalluri,et al.  BMP-7 counteracts TGF-β1–induced epithelial-to-mesenchymal transition and reverses chronic renal injury , 2003, Nature Medicine.

[35]  P. Dervan,et al.  Nuclear localization of pyrrole–imidazole polyamide–fluorescein conjugates in cell culture , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[36]  H. Sugiyama,et al.  Inhibition of transcription at a coding sequence by alkylating polyamide. , 2003, Journal of the American Chemical Society.

[37]  J. Dinman,et al.  An in vivo dual-luciferase assay system for studying translational recoding in the yeast Saccharomyces cerevisiae. , 2003, RNA.

[38]  S. Klahr,et al.  Obstructive nephropathy and renal fibrosis: The role of bone morphogenic protein-7 and hepatocyte growth factor. , 2003, Kidney international. Supplement.

[39]  E. Wagner,et al.  Retrofitting BACs with G418 resistance, luciferase, and oriP and EBNA-1 – new vectors for in vitro and in vivo delivery , 2003, BMC biotechnology.

[40]  G. Amdam,et al.  Disruption of vitellogenin gene function in adult honeybees by intra-abdominal injection of double-stranded RNA , 2003, BMC biotechnology.

[41]  H. Sugiyama,et al.  Biology of N-methylpyrrole-N-methylimidazole hairpin polyamide. , 2004, Biological & pharmaceutical bulletin.

[42]  Christina M. Taylor,et al.  Allosteric inhibition of zinc-finger binding in the major groove of DNA by minor-groove binding ligands. , 2004, Biochemistry.

[43]  H. Sugiyama,et al.  Sequence-specific gene silencing in mammalian cells by alkylating pyrrole-imidazole polyamides. , 2004, Journal of the American Chemical Society.

[44]  P. Sanders.  Salt intake, endothelial cell signaling, and progression of kidney disease. , 2004, Hypertension.